收费全文 | 44840篇 |
免费 | 3581篇 |
国内免费 | 124篇 |
耳鼻咽喉 | 359篇 |
儿科学 | 1899篇 |
妇产科学 | 1364篇 |
基础医学 | 5930篇 |
口腔科学 | 703篇 |
临床医学 | 5185篇 |
内科学 | 8567篇 |
皮肤病学 | 865篇 |
神经病学 | 4933篇 |
特种医学 | 930篇 |
外国民族医学 | 3篇 |
外科学 | 4831篇 |
综合类 | 498篇 |
现状与发展 | 1篇 |
一般理论 | 79篇 |
预防医学 | 5620篇 |
眼科学 | 749篇 |
药学 | 2963篇 |
中国医学 | 75篇 |
肿瘤学 | 2991篇 |
2024年 | 67篇 |
2023年 | 660篇 |
2022年 | 945篇 |
2021年 | 2340篇 |
2020年 | 1383篇 |
2019年 | 1975篇 |
2018年 | 2274篇 |
2017年 | 1483篇 |
2016年 | 1641篇 |
2015年 | 1736篇 |
2014年 | 2288篇 |
2013年 | 2838篇 |
2012年 | 4169篇 |
2011年 | 4011篇 |
2010年 | 2038篇 |
2009年 | 1729篇 |
2008年 | 2682篇 |
2007年 | 2695篇 |
2006年 | 2329篇 |
2005年 | 2156篇 |
2004年 | 1837篇 |
2003年 | 1522篇 |
2002年 | 1351篇 |
2001年 | 208篇 |
2000年 | 156篇 |
1999年 | 219篇 |
1998年 | 251篇 |
1997年 | 156篇 |
1996年 | 138篇 |
1995年 | 131篇 |
1994年 | 126篇 |
1993年 | 109篇 |
1992年 | 75篇 |
1991年 | 81篇 |
1990年 | 59篇 |
1989年 | 55篇 |
1988年 | 44篇 |
1987年 | 47篇 |
1986年 | 44篇 |
1985年 | 48篇 |
1984年 | 47篇 |
1983年 | 36篇 |
1982年 | 37篇 |
1981年 | 36篇 |
1980年 | 41篇 |
1979年 | 32篇 |
1978年 | 29篇 |
1977年 | 17篇 |
1974年 | 23篇 |
1972年 | 16篇 |
Area covered: The current review is provided to update recent developments in the clinical application of cyclin/CDK inhibitors to breast cancer with a focus on the anti-tumor immune response.
Expert opinion: The cyclin D1 gene encodes the regulatory subunit of a proline-directed serine-threonine kinase that phosphorylates several substrates. CDKs possess phosphorylation site selectivity, with the phosphate-acceptor residue preceding a proline. Several important proteins are substrates including all three retinoblastoma proteins, NRF1, GCN5, and FOXM1. Over 280 cyclin D3/CDK6 substrates have b\een identified. Given the diversity of substrates for cyclin/CDKs, and the altered thresholds for substrate phosphorylation that occurs during the cell cycle, it is exciting that small molecular inhibitors targeting cyclin D/CDK activity have encouraging results in specific tumors. 相似文献
Background
The objective of the study was to evaluate the outcomes of clinically localized prostate cancer treated with prostatectomy versus radiation therapy within the context of a prospective prostate cancer screening study.Patients and Methods
Within the PLCO (Prostate, Lung, Colorectal, and Ovary) trial, patients who were diagnosed with clinically localized prostate cancer and subsequently received treatment with prostatectomy or radiation therapy (with or without hormonal treatment) were included. Univariate and multivariate Cox regression analyses were then performed to determine factors affecting overall and prostate cancer-specific survival. Factors with P < .05 in univariate analysis were included in the multivariate analysis.Results
A total of 3953 patients were included in the current analysis. These included 2044 patients treated with prostatectomy and 1909 patients treated with radiation therapy with or without hormonal treatment. In an adjusted multivariate analysis for factors affecting overall survival, prostatectomy was associated with better overall survival compared with radiation therapy (hazard ratio, 0.548; 95% confidence interval [CI], 0.440- 681; P < .001). Likewise, in an adjusted multivariate analysis for factors affecting prostate cancer-specific survival, prostatectomy was associated with better prostate cancer-specific survival compared with radiation therapy (hazard ratio, 0.485; 95% CI, 0.286- 0.822; P = .007). Similar findings were found with propensity score matching and repeating the same analyses on the post-matching cohort.Conclusion
Prostatectomy seems to predict better overall and prostate cancer-specific survival compared with radiation therapy among patients with clinically localized prostate cancer diagnosed within the PLCO trial. 相似文献Design: Forty-two patients participating in the Task Shifting Strategy for Hypertension program (23 males, 19 females, and mean age 61. 7 years) completed in-depth, qualitative interviews. Interviews were transcribed, and key words and phrases were extracted and coded using the PEN-3 Cultural Model as a guide through open and axial coding techniques, thus allowing rich exploration of the data.
Results: Emergent themes included patients’ perceptions of hypertension, which encompassed misperceptions of hypertension and blood pressure control. Additional themes included enablers and barriers to hypertension management, and how the intervention nurtured lifestyle change associated with blood pressure control. Primary enabling factors included the supportive nature of TASSH nurses, while notable barriers were financial constraints and difficulty accessing medication. Nurturing factors included the motivational interviewing and patient counseling which instilled confidence in the patients that they could make lasting behavior changes.
Conclusions: This study offers a unique perspective of blood pressure control by examining how patients view an on-going task-shifting initiative for hypertension management. The results of this study shed light on factors that can help and hinder individuals in low-resource settings with long-term blood pressure management. 相似文献